• Sign In
  • Home
  • News
    • Politics
      • White House
      • Senate
      • House
      • Campaigns
  • Policy
  • 2026 Election
  • Opinion
    • Editorials
    • Op-Eds
  • In Focus
  • Restoring America
  • Magazine
  • Watch
  • Sponsored
    • Powering Progress
    • ASAE – Association Leadership
    • Examining Tax Reform
    • Fix TSCA
    • National Parks
    • Inside the Corn Belt
  • TWS Archive
Search
LogoWashington Examiner
Subscribe
LogoWashington Examiner
Sign in
Subscribe
  • News
    • Politics
      • Trump Administration
      • White House
      • Senate
      • House
      • Campaigns
    • Business
    • World
    • Investigations
    • Justice
    • Supreme Court
    • Crime
    • Entertainment
    • Washington Secrets
  • Policy
    • Defense
    • National Security
    • Energy and Environment
    • Education
    • Immigration
    • Finance and Economy
    • Healthcare
    • Foreign Policy
    • Tech
    • Infrastructure
    • Space
  • 2026 Election
  • Trump Administration
  • IN FOCUS
  • Commentary
    • Columnists
    • Editorials
    • Think Tanks
    • Beltway Confidential
    • Op-Eds
  • Restoring America
    • Patriotism and Unity
    • Faith, Freedom, and Self-Reliance
    • Courage, Strength, and Optimism
    • Equality, Not Elitism
    • Community and Family
    • Fairness and Justice
    • Mission
  • Watch
  • Magazine
    • Magazine
    • Quarterly Briefing
    • Archives
    • Games
  • Sponsored
    • Powering Progress
    • ASAE – Association Leadership
    • National Parks
    • Examining Tax Reform
    • Fix TSCA
    • Inside the Corn Belt
  • Newsletters
More
    Home Tags Pharmaceutical Industry

    Tag: Pharmaceutical Industry

    A new report suggests that because people who were uninsured were able to get government-funded Medicaid coverage under Obamacare, they are now receiving more access to prescription painkillers like OxyContin. (AP Photo/Toby Talbot, File)
    Healthcare

    Obamacare a contributing factor to opioid epidemic: GOP report

    Kimberly Leonard -
    January 17, 2018 4:49 pm
    0
    The 2012 meningitis outbreak traceable to New England Compounding Center is the most infamous case of profit-driven harm. (AP Photo/Steven Senne)
    Healthcare

    Fixing a crisis of confidence in drug compounding

    Doris Browne -
    January 16, 2018 12:00 pm
    0
    Heidi Heitkamp called Alex Azar, a former pharmaceuticals executive and Department of Health and Human Services veteran under the George W. Bush administration,
    Healthcare

    Heidi Heitkamp will support HHS pick Alex Azar

    Robert King -
    January 11, 2018 7:32 pm
    0
    The pace of dealmaking among pharmaceutical businesses is expected to pick up in the next six to 12 months, in part because of the Tax Cuts and Jobs Act passed in December.
    Business

    Big Pharma goes shopping as tax bill returns almost $200 billion cash to US

    James Langford -
    January 9, 2018 10:44 pm
    0
    Healthcare

    Trump’s HHS pick: I don’t know if any brand-name drug price has ever been lowered

    Robert King -
    January 9, 2018 4:39 pm
    0
    So far legislation to tackle high drug prices has not been high on the GOP's legislative agenda for 2018, as other issues such as immigration, infrastructure and welfare reform crowd out time in an election year.
    Healthcare

    Maryland to fight pharmacist ‘gag rule’ on drug costs

    Robert King -
    January 9, 2018 5:01 am
    0
    The legislation would allow terminally ill patients to access experimental drugs. (iStock photo)
    Healthcare

    Koch-backed group urges passage of ‘Right to Try’ bill allowing experimental drugs for terminal patients

    Kimberly Leonard -
    January 8, 2018 2:31 pm
    0
    Many of the recommendations offered by the National Academies of Sciences, Engineering, and Medicine aim at increasing competition by regulating pharmaceutical companies even more in order to decrease drug prices. But a more effective way to lower drug prices is to change the system so it actually reflects free market principles. (AP Photo/Jim Mone)
    Beltway Confidential

    Tom Coburn: Making medicine affordable is simple

    Tom Coburn -
    January 4, 2018 10:48 pm
    0
    In this article, Rep. Andy Biggs, R-Ariz., lists some of his legislative initiatives in Congress during 2017. (AP Photo/Ross D. Franklin)
    Education

    Rep. Andy Biggs: I kept my campaign promises by introducing or sponsoring these bills

    Rep. Andy Biggs -
    December 29, 2017 8:42 pm
    0
    In this 2006 photo, Wal-Mart pharmacy technician Mark Pool fills a generic anti-inflammatory prescription at a Little Rock, Ark., Wal-Mart Super Center store. While the Constitution allows for patents, patents are temporary monopolies, meaning that drug companies want to extend their effective life as much as possible - much to the detriment of generics. (AP Photo/Mike Wintroath)
    Healthcare

    Congress can liberate drugs that come off their patents

    Peter Ferrara -
    December 26, 2017 5:01 am
    0
    1...103104105...159Page 104 of 159
    LogoWashington Examiner
    Do Not Sell or Share My Personal Information
    Facebook
    Twitter
    Youtube

    NEWS

    • Politics
      • White House
      • Senate
      • House
      • Campaigns
    • Business
    • World
    • Investigations
    • Justice
    • Supreme Court
    • Crime
    • Washington Secrets
    • Entertainment
    • Sports

    POLICY

    • Defense
    • National Security
    • Energy
    • Immigration
    • Finance and Economy
    • Healthcare
    • Foreign Policy
    • Tech
    • Infrastructure
    • Space

    COMMENTARY

    • Columnists
    • Editorials
    • Think Tanks
    • Beltway Confidential
    • Op-Eds

    RESTORING AMERICA

    • Patriotism and Unity
    • Faith, Freedom, and Self-Reliance
    • Courage, Strength, and Optimism
    • Equality, Not Elitism
    • Community and Family
    • Fairness and Justice
    • Mission
    • WATCH
    • IN FOCUS
    • NEWSLETTERS
    • MAGAZINE ARCHIVE
    • Policies and Standards
    • Terms Of Service
    • Subscription Terms of Use
    • Privacy Policy
    • Your Privacy Choices
    • Transparency In Coverage
    • Advertise
    • Subscribe
    • Contact
    • Careers
    • Staff
    • About Examiner
    • Facebook
    • Twitter
    • © Copyright 2026. Washington Examiner. All Rights Reserved.